About

Daniel Lock joined Vectura in 2010 and is a pharmaceutical development specialist, working on a wide array of product and technology development workstreams – from DPI generic programmes to cross-platform in-vitro/in-vivo correlation. Recently, he has been working with the Inhaled Product Solutions group as a Team Leader, bringing experience in early-phase development with the FOX® smart nebuliser. In 2022, he
resumed technology development and innovation workstreams relating to cross-platform understanding of formulation/device interactions to optimise performance.